Latest filing published 26 Jun 2026 for Stevanato Group S.p.A.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Donald e. Morel Jr. across 3 companies, led by Catalent, Inc., Integra Lifesciences Holdings Corp and Stevanato Group S.p.A. We count 9 filings; the first trade dates from 14 May 2021 and the latest from 15 June 2026.
Every open-market trade on record is a sale: 1 sale. No amount is published for 1 filing, which the totals therefore leave out. Besides market trades, the filings include 7 share grants. In 2026 alone, the filings show no purchases and 1 sale.
Most recently, on 26 June 2026, the filings show a share grant in Stevanato Group S.p.A. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations